According to Microchip Biotech's announcement, Dr. XIANPING LU, the chairman of the company proposed that the company use its own funds and/or self-raised funds to repurchase some A shares through centralized bidding transactions. The total repurchase capital is not less than 30 million yuan and no more than 50 million yuan. The repurchase price is not higher than 150% of the average stock trading price in the 30 trading days before the board of directors deliberates and approves the repurchase plan. The repurchase period is 12 months from the date the board of directors reviews and approves the repurchase plan. If not used up within 3 years, the repurchase shares are intended to be used for employee stock ownership plans or share incentives. Dr. XIANPING LU proposed not to trade the company's shares within the first 6 months, and there are no plans to increase or decrease holdings during the repurchase period. The board of directors will vote in favor of the repurchase bill. The repurchase is subject to approval procedures, and there is uncertainty.

According to Microchip Biotech's announcement, Dr. XIANPING LU, the chairman of the company proposed that the company use its own funds and/or self-raised funds to repurchase some A shares through centralized bidding transactions. The total repurchase capital is not less than 30 million yuan and no more than 50 million yuan. The repurchase price is not higher than 150% of the average stock trading price in the 30 trading days before the board of directors deliberates and approves the repurchase plan. The repurchase period is 12 months from the date the board of directors reviews and approves the repurchase plan. If not used up within 3 years, the repurchase shares are intended to be used for employee stock ownership plans or share incentives. Dr. XIANPING LU proposed not to trade the company's shares within the first 6 months, and there are no plans to increase or decrease holdings during the repurchase period. The board of directors will vote in favor of the repurchase bill. The repurchase is subject to approval procedures, and there is uncertainty.